Neogen (NEOG) Cash & Equivalents (2010 - 2026)

Neogen's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $159.9 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 25.21% year-over-year to $159.9 million in Q1 2026; TTM through Feb 2026 was $159.9 million, a 25.21% increase from a year earlier, with the FY2025 full-year figure at $129.0 million, down 24.39% from the prior year.
• Cash & Equivalents rose to $159.9 million in Q1 2026 per NEOG's latest filing, from $145.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $205.8 million in Q4 2023 and bottomed at $42.9 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $138.9 million (2025), against an average of $129.6 million.
• Across the five-year window, Cash & Equivalents plunged 41.65% in 2022 and soared 267.05% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $100.0 million in 2022, then soared by 105.76% to $205.8 million in 2023, then sank by 31.85% to $140.2 million in 2024, then climbed by 3.64% to $145.3 million in 2025, then gained by 10.02% to $159.9 million in 2026.
• Per Business Quant, the three latest NEOG Cash & Equivalents figures stand at $159.9 million (Q1 2026), $145.3 million (Q4 2025), and $138.9 million (Q3 2025).